Medcaptain Medical Technology Co. Ltd. Class H
2041.HK · Hong Kong Stock Exchange · HKD
6,40HKD
+0,44 (+7,38 %)Stand 10. Nov., 8:08
Kennzahlen
- Eröffnung
- 6,05
- Vortag
- 5,96
- Tagesspanne
- 6,05 – 6,60
- 52 Wochen
- 5,85 – 10,90
- Volumen
- 515.400
- Ø Volumen
- 619.015
- Börsenwert
- 3,07 Mrd. HKD
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 0,0
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Gewinn je Aktie · Erwartet |
|---|
| Gewinn je Aktie · Tatsächlich |
| Abweichung |
| Umsatz · Tatsächlich |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
1066.HKShandong Weigao Group Medical Polymer Company Limited3,35−0,30 %
1302.HKLifeTech Scientific Corporation1,575+6,78 %
1501.HKShanghai Kindly Medical Instruments Co., Ltd.29,40−3,16 %
1609.HKStar Sports Medicine Co., Ltd.52,55+3,04 %
1612.HKVincent Medical Holdings Limited0,6850,00 %
1696.HKSisram Medical Ltd1,78−1,11 %
2190.HKZylox-Tonbridge Medical Technology Co., Ltd.18,99+0,16 %
2216.HKBroncus Holding Corporation0,545+1,87 %
Über das Unternehmen
Medcaptain Medical Technology Co., Ltd. manufactures integrated perioperative medical devices in China, Europe, Asia, the Middle East, Africa, North America, and South America. It offers life support products, such as infusion systems, medication delivery products, anesthesia machines and vaporizers, workstations, imaging equipment, and other life support products, including airway management, pulmonary function testing devices, deep vein thrombosis (DVT) preventive pumps, vein illuminators, monitors, and veterinary life support products; minimally invasive intervention products, such as an endoscopic product portfolio for the diagnosis and treatment of conditions relating to the digestive system, including the gastrointestinal (GI) and hepatobiliary tracts, and the urological system; and In Vitro diagnostics products, such as thromboelastography analyzers, blood grouping analyzers, chemiluminescent immunoassay (CLIA) testing analyzers and reagent kits, and molecular diagnostics equipment and testing kits. The company sells its products through a chain of distributors globally. Medcaptain Medical Technology Co., Ltd. was formerly known as Shenzhen Yusheng Medical Technology Co., Ltd. and changed its name to Medcaptain Medical Technology Co., Ltd. in July 2023. Medcaptain Medical Technology Co., Ltd. was incorporated in 2011 and is based in Shenzhen, China.
Führung
- Yaoqi ZhongExecutive Vice Chairman & Deputy GM
- Jie LiuExecutive Chairman & GM
- Liu JieExecutive Chairman & GM
- Renzhong YanExecutive Director, Board Secretary & Joint Company Secretary
- Bin WangDeputy General Manager
- Jun LuoDeputy General Manager
- CEO
- Jie Liu
- Mitarbeitende
- 2.191
- Hauptsitz
- Shenzhen, GD, CN
- Sektor
- Healthcare
- Branche
- Medical - Devices
- Börsengang
- 7. Sept. 2026
- Website
- medcaptain.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.